 This study investigated the effects of delta-tocotrionol supplementation on glychemic control parameters in individuals with prediabetes. The results showed that participants who received delta-tocotrionol had significantly lower levels of fasting plasma glucose, glycosylated hemoglobin, insulin and homeostatic model assessment insulin resistance index compared to those who did not receive it. This suggests that delta-tocotrionol may be beneficial in improving glychemic control in individuals with prediabetes. Further clinical trials are required to confirm these findings. This article was authored by Farhana Suleiman, Dilshad Ahmed Khan, Muhammad Amjad Purvesh and others.